Comparative clinical and laboratory evaluation of the effectiveness of a nanodispersed silica-based drug with antimicrobial properties for the local treatment of purulent inflammatory diseases of the maxillofacial area

Authors

  • P Belyaev National Pirogov Memorial Medical University, Vinnytsia
  • O Shtatko National Pirogov Memorial Medical University, Vinnytsia
  • O Viltsanyuk National Pirogov Memorial Medical University, Vinnytsia

DOI:

https://doi.org/10.31636/prmd.v7i1.4

Keywords:

phlegmon, maxillofacial area, local treatment, nanosilica-based drug, changes in blood parameters, C-reactive protein, endogenous intoxication

Abstract

Background. The problem of purulent inflammatory diseases of the maxillofacial area remains one of the most pressing problems of modern dentistry and maxillofacial surgery. The aim of the study is to conduct a comparative evaluation of the effectiveness of a drug based on nanodispersed silica (NDS) with antimicrobial properties for the local treatment of purulent inflammatory diseases of the maxillofacial area.

Materials and methods. A comparative assessment of the postoperative period was performed in 71 patients with maxillofacial phlegmon, who were divided into two representative groups: comparison (39 patients), in whose local treatment of purulent wounds was carried out by conventional methods, and the main group (32 patients), where the local treatment was carried out using a drug based on NDC. The level of endogenous intoxication was determined by the level of C-reactive protein (CRP), by the level of blood metabolites of average mass (MAM) and leukocyte intoxication index (LII) in the blood serum. The data obtained were statistically processed and compared.

Results. During the study of the dynamics of СRР was found that starting from 3 days in the main group there was a tendency to its faster decrease and normalization before discharge, while in patients of the comparison group it was significantly higher (p < 0.05)., The level of MAM in patients of the comparison group remained significantly (p < 0.05) elevated throughout the treatment in the postoperative period, while in the main group it was on the verge of normal before discharge. Comparison group of patients had significantly higher LII during treatment and at the time of discharge from hospital (p < 0.05) than the main group.

Conclusions: The treatment of maxillofacial phlegmon by the developed method provided a more favorable course of the postoperative period than in the comparison group, as evidenced by a significantly (p < 0.05) faster normalization of endogenous intoxication blood parameters.

Downloads

Download data is not yet available.

References

1. Steblovskyi DV, Skikevich MG, Bondarenko VV. Structural Features Of Purulent Inflammatory Diseases Of The Maxillofacial Region In Residents Of The Poltava Region. Ukrainian Dental Almanac [Internet]. 2020 Dec 23;(4):50–2. Available from: https://doi.org/10.31718/2409-0255.4.2020.09

2. Ogle OE. Odontogenic Infections. Dental Clinics of North America [Internet]. 2017 Apr;61(2):235–52. Available from: https://doi.org/10.1016/j.cden.2016.11.004

3. Weise H, Naros A, Weise C, Reinert S, Hoefert S. Severe odontogenic infections with septic progress – a constant and increasing challenge: a retrospective analysis. BMC Oral Health [Internet]. 2019 Aug 2;19(1):173. Available from: https://doi.org/10.1186/s12903-019-0866-6

4. Kamiński B, Błochowiak K, Kołomański K, Sikora M, Karwan S, Chlubek D. Oral and Maxillofacial Infections—A Bacterial and Clinical Cross-Section. Journal of Clinical Medicine [Internet]. 2022 May 12;11(10):2731. Available from: https://doi.org/10.3390/jcm11102731

5. Tymofieiev O, Ushko N, Tymofieiev O, Yarifa M, Fesenko I. Prevention of Inflammatory Complications upon Surgeries in Maxillofacial Region. Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology [Internet]. 2017 Jun 30;1(2):105–12. Available from: https://doi.org/10.23999/j.dtomp.2017.2.8

6. Gadicherla S, Manglani K, Pentapati KC, Kudva A, Aramanadka C, Chandravel R. Profile of Patients with Maxillofacial Space Infections and Associated Risk Factors. Caruso G, editor. The Scientific World Journal [Internet]. 2024 Apr 9;2024:1–6. Available from: https://doi.org/10.1155/2024/9304671

7. Lewandowski B, Pakla P, Wołek W, Jednakiewicz M, Nicpoń J. A fatal case of descending necrotizing mediastinitis as a complication of odontogenic infection. A . Polish Journal of Cardio-Thoracic Surgery [Internet]. 2014;3:324–8. Available from: https://doi.org/10.5114/kitp.2014.45685

8. Nugroho SS, Hardianto A, Riawan L. Surgical management of necrotizing fasciitis due to odontogenic infection with sepsis: case report. Journal of Dental Health, Oral Disorders & Therapy [Internet]. 2017 Jan 23;6(2). Available from: https://doi.org/10.15406/jdhodt.2017.06.00190

9. Atoeva MA. Ways To Optimize Local Treatment Of Purulent¬Inflammatory Diseases In The Face And Oral Cavity. European Journal Of Modern Medicine And Practice [Internet]. 2024;4(6):99–104. Available from: https://inovatus.es/index.php/ejmmp/article/view/3418

10. Gayratovna SR. The Course of the Wound Process in Purulent¬Inflammatory Diseases of the Maxillofacial Region. Central Asian Journal of Medical and Natural Science. 2022;3(4):255–259. https://doi.org/10.17605/cajmns.v3i4.1018

11. Kuzniak NB, Dmytrenko RR, Bambuliak AV, Perebiynis PP, Tkachyk SV. Treatment of patients with adenophlegmons of maxillofacial area by the drugs with sorption and proteolytic properties [Likuvannya khvorykh z adenoflehmonamy shchelepno¬litsevoyi dilyanky preparatamy iz sorbtsiynymy ta proteolitychnymy vlastyvostyamy]. Clinical Dentistry [Internet]. 2020 Jul 1;(1):12–6. Available from: https://doi.org/10.11603/2311-9624.2020.1.11216 [In Ukrainian]

12. Pagana KD, Pagana TJ. Mosby’s manual of diagnostic and laboratory tests (14th ed.). St. Louis: Elsevier; 2019.

13. Viltsaniuk OA, Mazur MV. Justification Of The Effectiveness Of The Use Of Dalmaxin Rectal Suppositories (Thiotriazolin) In The Complex Treatment Of Acute Paraproctitis [Obgruntuvannya efektyvnosti zastosovuvannya rektalʹnykh supozytoriv «Dalmaksin» (Tiotryazolin) pry kompleksnomu likuvanni hostroho paraproktytu]. Kharkiv Surgical Schoo [Internet]. 2020Feb.20;(1):54–62. Available from: https://doi.org/10.37699/2308-7005.1.2020.06 [In Ukrainian]

14. Kal’f¬-Kalif YY. About the leukocyte index of intoxication and its practical significance [O lejkocitarnom indekse intoksikacii i ego prakticheskom znachenii]. Vrachebnoe delo. 1941;1:31¬ 33. [In Russian]

15. Bagul R, Chandan S, Sane VD, Patil S, Yadav D. Comparative Evaluation of C-Reactive Protein and WBC Count in Fascial Space Infections of Odontogenic Origin. Journal of Maxillofacial and Oral Surgery [Internet]. 2016 Sep 1;16(2):238–42. Available from: https://doi.org/10.1007/s12663-016-0953-z

16. Stathopoulos P, Igoumenakis D, Shuttleworth J, Smith W, Ameerally P. Predictive factors of hospital stay in patients with odontogenic maxillofacial infections: the role of C-reactive protein. British Journal of Oral and Maxillofacial Surgery [Internet]. 2017 May;55(4):367–70. Available from: https://doi.org/10.1016/j.bjoms.2016.11.004

17. Xiaojie L, Hui L, Zhongcheng G, Chenggang W, Yaqi N. The Predictive Value of Interleukin-6 and Neutrophil-Lymphocyte Ratio in Patients with Severe and Extremely Severe Oral and Maxillofacial Space Infections. Gargalionis A, editor. BioMed Research International [Internet]. 2021 Jan 28;2021:1–8. Available from: https://doi.org/10.1155/2021/2615059

18. Altman DG. Practical Statistics for Medical Research [Internet]. Chapman and Hall/CRC; 1990. Available from: https://doi.org/10.1201/9780429258589

Порівняльна клініко-лабораторна оцінка ефективності застосування препарату на основі нанодисперсного кремнезему з антимікробними властивостями для місцевого лікування гнійно-запальних захворювань щелепно-лицевої ділянки

Published

2024-09-02

How to Cite

1.
Comparative clinical and laboratory evaluation of the effectiveness of a nanodispersed silica-based drug with antimicrobial properties for the local treatment of purulent inflammatory diseases of the maxillofacial area. prmd [Internet]. 2024 Sep. 2 [cited 2026 Jul. 11];7(1):25-31. Available from: https://perioperative.org.ua/index.php/prtmdc/article/view/123